As Eli Lilly's weight-loss drug Zepbound gains ground in the US against Novo Nordisk's Wegovy, some doctors say their guiding principle for writing prescriptions...
Certain genes may identify patients with obesity who are most likely to respond strongly to Novo Nordisk's weight-loss drug Wegovy, researchers reported on Monday.
The...
Patients on Eli Lilly's weight-loss drug Zepbound substantially regained weight nearly a year after stopping treatment, according to full results of a study published...